Journals / Türk Beyin Damar Hastalıkları Dergisi / 2022 / Cilt: 28 - Sayı: 1

EVALUATION OF MECHANICAL THROMBECTOMY RESULTS IN PATIENTS WHO DEVELOPED ACUTE ISCHEMIC STROKE WHILE USING NEW GENERATION ORAL ANTICOAGULANTS

YENİ KUŞAK ORAL ANTİKOAGÜLAN KULLANIRKEN AKUT İSKEMİK İNME GELİŞEN HASTALARDA MEKANİK TROMBEKTOMİ SONUÇLARININ DEĞERLENDİRİLMESİ

Pages
38–45
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, given the complexity of the clinical situation, it would be beneficial to establish standardized protocols for the development of endovascular treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: Direct oral anticoagulants have demonstrated efficacy and safety in cerebrovascular prevention.
📊
Key Findings & Data:METHODS: A retrospective study of prospectively collected data based on data from the registry of the Osmangazi University was performed between January 2015 and December 2019.
💡
Conclusion & Impact:In conclusion, given the complexity of the clinical situation, it would be beneficial to establish standardized protocols for the development of endovascular treatment.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: Direct oral anticoagulants have demonstrated efficacy and safety in cerebrovascular prevention. We aimed to investigate the safety and efficacy of mechanical thrombectomy in patients with major vascular occlusion while receiving DOAC, and to evaluate the clinical characteristics and treatment outcomes of patients. METHODS: A retrospective study of prospectively collected data based on data from the registry of the Osmangazi University was performed between January 2015 and December 2019. All patients have cardioembolic etiology. We collected the demographics, clinical and brain imaging, and stroke etiology. A good outcome was defined as a modified Rankin Scale (mRS) score ≤0-2 at three months follow-up. RESULTS: 140 patients were included. Patients were classified and compared into two study groups according to DOAC at admission. There were no differences in basic demographics, clinical characteristics, and vascular risk factors between the two groups, A total of 23 patients adherent with DOAC were admitted, All patients, except 2, were using DOAC regularly. 69.6% of the patients receiving DOAC and 84.3% of the other group were fully recanalized (TICI 2b-3) (p=0.18). No significant difference was observed in intracranial hemorrhage, The Thrombolysis in Cerebral Infarction (TICI) score, and mortality between patients with and without DOAC. The patients with mRS ≤0-2 were 26.1% in the DOAC group and 53.8% in the other group. This difference was statistically significant (p=0.02). DISCUSSION AND CONCLUSION: Despite similar recanalization rates, 3rd-month mRS scores were worse in patients receiving DOAC. In conclusion, given the complexity of the clinical situation, it would be beneficial to establish standardized protocols for the development of endovascular treatment.

Özet

GİRİŞ ve AMAÇ: Direkt oral antikoagülanların, serebrovasküler hastalıkları önlemede etkinlik ve güvenirlikleri gösterilmiştir. DOAC alırken majör damar tıkanıklığı olan hastalarda mekanik trombektominin güvenliğini ve etkinliğini araştırmayı ve hastaların klinik özelliklerini ve tedavi sonuçlarını değerlendirmeyi amaçladık. YÖNTEM ve GEREÇLER: Ocak 2015 ile Aralık 2019 tarihleri arasında Osmangazi Üniversitesi kayıtlarından elde edilen verilere dayalı olarak prospektif toplanan verilerin retrospektif analizi yapıldı. Tüm hastalarda inme etyolojisi kardiyoembolikti. Hastaların demografik bilgileri, klinik ve beyin görüntülemesini ve inme etiyolojisini topladık. İyi klinik sonlanım, üç aylık takipte modifiye Rankin Skalası (mRS) skoru ≤0-2 olarak tanımlandı. BULGULAR: Çalışmaya140 hasta dahil edildi. Hastalar başvuruda DOAC alma durumuna göre sınıflandırıldı ve gruplar karşılaştırıldı. İki grup arasında temel demografik özellikler, klinik özellikler ve vasküler risk faktörleri açısından fark yoktu, DOAC alan toplam 23 hasta vardı, 2 hasta dışında tüm hastalar düzenli olarak DOAC kullanıyordu. DOAC alan hastaların %69,6'sı ve diğer grubun %84,3'ü tamamen rekanalize edildi (TICI 2b-3) (p=0,18). DOAC olan ve olmayan hastalar arasında intrakraniyal kanama, The Trombolysis in Cerebral Infarction (TICI) skoru ve mortalite açısından anlamlı bir fark gözlenmedi. mRS ≤0-2 olan hastalar DOAK grubunda %26.1, diğer grupta %53,8 idi. Bu fark istatistiksel olarak anlamlıydı (p=0.02). TARTIŞMA ve SONUÇ: Benzer rekanalizasyon oranlarına rağmen DOAK alan hastalarda 3. ay mRS skorları daha kötüydü. Sonuç olarak, klinik durumun karmaşıklığı göz önüne alındığında, endovasküler tedavinin geliştirilmesi için standart protokoller oluşturmak faydalı olacaktır.

🔖

Cite This Article

ÖZDEMİR, A. Ö., ERYILDIZ, E. S., MEMMEDOVA, F., AKARSU, F. G., AYKAÇ, Ö., MEHDİYEV, Z., KAYA, F. A. (2022). EVALUATION OF MECHANICAL THROMBECTOMY RESULTS IN PATIENTS WHO DEVELOPED ACUTE ISCHEMIC STROKE WHILE USING NEW GENERATION ORAL ANTICOAGULANTS. Türk Beyin Damar Hastalıkları Dergisi, Cilt: 28 - Sayı: 1, 38–45. https://ajindex.com/articles/620284

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dentali F, Riva N, Crowther M, et al. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature. Circulation 2012; 126(20): 2381-2391
  2. Zirlik A, Bode C. Vitamin k antagonists: Relative strengths and weaknesses vs. Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. Journal of thrombosis and thrombolysis 2017; 43(3): 365-379
  3. Giray S, Ozdemir O, Baş DF, et al. Does stroke etiology play a role in predicting outcome of acute stroke patients who underwent endovascular treatment with stent retrievers? Journal of the neurological sciences 2017; 372: 104-109
  4. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. The Lancet 2016; 387(10029): 1723-1731
  5. Adams Jr HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. stroke 1993; 24(1): 35-41
  6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England journal of medicine 2008; 359(13): 1317-1329
  7. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New England journal of medicine 2009; 361(12): 1139-1151
  8. Sjögren V, Byström B, Renlund H, et al. Non-vitamin k oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study. PloS one 2017; 12(7): e0181000. 9. Černík D, Šaňák D, Divišová P, et al. Mechanical thrombectomy in patients with acute ischemic stroke on anticoagulation therapy. CardioVascular and Interventional Radiology 2018; 41(5): 706-711
  9. Liang J, Liu W, Sun J, et al. Analysis of the risk factors for the short-term prognosis of acute ischemic stroke. International journal of clinical and experimental medicine 2015; 8(11): 21915
  10. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the american heart association/american stroke association. stroke 2019; 50(12): e344-e418
  11. Flint AC, Avins AL, Eaton A, et al. Risk of